Tubacin, a selective HDAC6 inhibitor, was found to alleviate ischemic brain injury in T2D mice with focal cerebral ischemia by endorsing eNOS expression in an HDAC6-dependent mechanism [330]. This evidence concerns the gene HDAC6 and type 2 diabetes mellitus.